Corporate News 04-Feb-22
Jagsonpal Pharmaceuticals to announce Quarterly Result
On 11 February 2022
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2022.
Previous News
Jagsonpal Pharmaceuticals standalone net profit declines 94.60% in the June 2022 quarter
( Results - Announcements 10-Aug-22 08:12 )
Jagsonpal Pharmaceuticals to declare Quarterly Result
( Corporate News - 27-Jan-24 16:27 )
Jagsonpal Pharmaceuticals grants 10.47 lakh stock options
( Corporate News - 19-Sep-22 09:07 )
Jagsonpal Pharmaceuticals standalone net profit rises 18.92% in the September 2015 quarter
( Results - Announcements 13-Nov-15 15:35 )
Board of Jagsonpal Pharmaceuticals approves divestment of its Faridabad unit
( Corporate News - 03-Nov-23 15:06 )
Jagsonpal Pharmaceuticals to hold board meeting
( Corporate News - 08-Nov-14 10:54 )
Jagsonpal Pharmaceuticals schedules AGM
( Corporate News - 08-Sep-21 10:10 )
Jagsonpal Pharmaceuticals cancels board meeting
( Corporate News - 20-Jan-22 09:58 )
Jagsonpal Pharmaceuticals to discuss results
( Corporate News - 27-Oct-23 16:48 )
Jagsonpal Pharmaceuticals net profit rises 197.44% in the December 2011 quarter
( Results - Announcements 13-Feb-12 18:24 )
Refex Industries Ltd leads gainers in 'B' group
( Hot Pursuit - 18-Nov-20 12:16 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
